ETF Managers Group’s Nektar Therapeutics NKTR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-1,200
| Closed | -$351K | – | 756 |
|
|
2021
Q1 | $351K | Buy |
1,200
+161
| +15% | +$47.1K | 0.01% | 574 |
|
|
2020
Q4 | $279K | Buy |
1,039
+93
| +10% | +$25K | 0.01% | 556 |
|
|
2020
Q3 | $240K | Sell |
946
-550
| -37% | -$140K | 0.01% | 557 |
|
|
2020
Q2 | $503K | Buy |
+1,496
| New | +$503K | 0.02% | 269 |
|
|
2019
Q3 | – | Sell |
-1,127
| Closed | -$586K | – | 570 |
|
|
2019
Q2 | $586K | Sell |
1,127
-307
| -21% | -$160K | 0.02% | 237 |
|
|
2019
Q1 | $723K | Sell |
1,434
-126
| -8% | -$63.5K | 0.04% | 205 |
|
|
2018
Q4 | $769K | Sell |
1,560
-222
| -12% | -$109K | 0.04% | 203 |
|
|
2018
Q3 | $1.63M | Buy |
1,782
+456
| +34% | +$417K | 0.06% | 141 |
|
|
2018
Q2 | $6.6K | Buy |
+1,326
| New | +$6.6K | 0.48% | 45 |
|